Please assess the completion status of the following clinical trial:

Trial Title: Lipid Efficacy Study (0524B-022)(COMPLETED)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Patients 18 to 85 years of age with primary hypercholesterolemia or mixed hyperlipidemia~* LDL-C between 130 and 190 mg/L (Category I) and 130 and 160 mg/L (Category II) and triglycerides \</= 350 mg/dL.~Exclusion Criteria:~* A condition which, in the opinion of the investigator, might pose a risk to the patient or interfere with participating in the study~* Patients with \<80% compliance~* Patients with certain medical conditions~* Patients taking certain concomitant medications and/or with unstable doses of medications~* Or those with a history of CHD/CHD equivalent or diabetes

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).